Posted on: April 12, 2022
The BC CTC and CTRAWG recommend that remdesivir be used as the first-line alternative IV treatment if nirmatrelvir-ritonavir (PAXLOVID) cannot be prescribed.
Practice Tool #1 – Assessment Guide for Clinicians.
Practice Tool #2 – Definitions of CEV/ Immunosuppressed.
Therapeutic Update RE: Operationalizing Remdesivir
Information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information.